Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
20/05/2022 - 4 minutes
Clinical trial
Sponsored
by LINK Medical
The Trial of the Future: Using Digital Technologies to Enable Decentralized Trials
Conducting a successful clinical trial is by no means an easy endeavor; it requires extensive…
22/03/2022 - 7 minutes
Sponsored
by Precision for Medicine
Using the Full Potential of Circulating Tumor Cells for Oncology Clinical Trials
Circulating tumor cell counts are powerful prognostic factors for cancer patients. Recent research has found…
09/02/2022 - 5 minutes
Reforms of EU Clinical Trial Regulations Bring Cautious Optimism
The EU’s clinical trial regulations received a major overhaul at the end of January 2022…
08/02/2022 - 5 minutes
Sponsored
by Link Medical
Why Biostatisticians are Essential for Successful Clinical Trial Management
The role of biostatisticians goes far beyond analyzing data at the end of a clinical…
04/01/2022 - 5 minutes
Sponsored
by PSI CRO
Streamlining Clinical Trial Execution with Robotic Process Automation
Conducting clinical trials on time ensures that innovative treatments can reach patients in need. In…
15/12/2021 - 6 minutes
Automation Can Solve Diversity Issues in Clinical Trial Recruitment
How can we make clinical trial recruitment more reflective of the real world? Technology is…
10/11/2021 - 6 minutes
Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…
26/10/2021 - 5 minutes
As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues
Johnson & Johnson became the latest company to have a failed vaccine trial against HIV…
08/09/2021 - 5 minutes
AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
02/09/2021 - 5 minutes
BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
29/04/2021 - 5 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
27/04/2021 - 6 minutes
